For this reason, she explains, drugs that act indiscriminately on all NMDA receptors have unacceptable psychiatric side ...

Depression and anxiety rank among the top global health challenges. Since 1990, these disorders have surged, placing them in ...

Efforts have been made in recent years to clarify the value of exercise as an adjunctive or independent treatment for major ...

de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .

The work by UB neuroscientists provides key insight into how the “lifesaving” medication offers almost instant relief of symptoms of major depression.

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...

As psychedelic medicine inches closer to mainstream acceptance, researchers have tackled a crucial question: How many ...

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to revoluti ...